RNS Number : 1355V
Stenprop Limited
05 August 2020
 

 

 

 

                 STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP    JSE share code: STP

ISIN:  GG00BFWMR296

("Stenprop" or the "Company")

 

 

DEALINGS IN SECURITIES BY A DIRECTOR, ASSOCIATES OF DIRECTORS AND A PERSON DISCHARGING MANAGERIAL RESPONSIBILITY

 

 

5 August 2020

 

Stenprop shareholders are referred to previous announcements in respect of the offer to receive the final dividend of 3.375 pence per share for the six months ended 31 March 2020 either as a cash dividend or a scrip dividend in return for Stenprop shares (the "Scrip Dividend"). Shareholders are advised of the following information relating to dealings in securities by a director, by associates of directors and by a person discharging managerial responsibility in terms of the Scrip Dividend. Clearance to deal was granted in respect of all Scrip Dividend elections.

 

Name of director:

Paul Arenson

Transaction date:

3 August 2020

Class of securities:

Ordinary shares

Number of securities:

11,529

Deemed total value of the transaction:

GBP 13,562.05 (at a value of GBP 1.176342 per share)

Nature of transaction:

Election to receive shares pursuant to the Scrip Dividend as an off-market transaction

Nature and extent of director's interest:

Direct beneficial

 

Name of associate

Jabali Enterprises Limited

Name of director and relationship to director:

Paul Arenson, who is a discretionary beneficiary of the Lonat Trust which has a beneficial interest in Jabali Enterprises Limited

Transaction date:

3 August 2020

Class of securities:

Ordinary shares

Number of securities:

155,431

Deemed total value of the transaction:

GBP 182,840.01 (at a value of GBP 1.176342 per share)

Nature of transaction:

Election to receive shares pursuant to the Scrip Dividend as an off-market transaction

Nature and extent of director's interest:

Indirect beneficial

 

Name of associate

Saruga Trust

Name of director and relationship to director:

Paul Arenson, who is a discretionary beneficiary of the Saruga Trust

Transaction date:

3 August 2020

Class of securities:

Ordinary shares

Number of securities:

88,015

Deemed total value of the transaction:

GBP 103,535.74 (at a value of GBP 1.176342 per share)

Nature of transaction:

Election to receive shares pursuant to the Scrip Dividend as an off-market transaction

Nature and extent of director's interest:

Indirect beneficial

 

Name of associate

Lonat Trust

Name of director and relationship to director:

Paul Arenson, who is a discretionary beneficiary of the Lonat Trust

Transaction date:

3 August 2020

Class of securities:

Ordinary shares

Number of securities:

57,858

Deemed total value of the transaction:

GBP 68,060.80 (at a value of GBP 1.176342 per share)

Nature of transaction:

Election to receive shares pursuant to the Scrip Dividend as an off-market transaction

Nature and extent of director's interest:

Indirect beneficial

 

Name of associate:

Zowert Properties Limited

Name of director and relationship to director:

Paul Arenson, who is a discretionary beneficiary of the Saruga Trust, which has a beneficial interest in Zowert Properties Limited

Transaction date:

3 August 2020

Class of securities:

Ordinary shares

Number of securities:

48,123

Deemed total value of the transaction:

GBP 56,609.11 (at a value of GBP 1.176342 per share)

Nature of transaction:

Election to receive shares pursuant to the Scrip Dividend as an off-market transaction

Nature and extent of director's interest:

Indirect beneficial

 

Name of associate:

Millicent Limited

Name of director and relationship to director:

Patsy Watson, who is a discretionary beneficiary of the Swallow Trust which has a beneficial interest in Millicent Limited

Transaction date:

3 August 2020

Class of securities:

Ordinary shares

Number of securities:

119,660

Deemed total value of the transaction:

GBP 140,761.08 (at a value of GBP 1.176342 per share)

Nature of transaction:

Election to receive shares pursuant to the Scrip Dividend as an off-market transaction

Nature and extent of director's interest:

Indirect beneficial

 

Name:

Neil Marais

Position:

Director of Stenprop (Swiss) Limited and Stenprop Trafalgar Limited, being subsidiaries of Stenprop

Transaction date:

3 August 2020

Class of securities:

Ordinary shares

Number of securities:

314

Deemed total value of the transaction:

GBP 369.37 (at a value of GBP 1.176342 per share)

Nature of transaction:

Election to receive shares pursuant to the Scrip Dividend as an off-market transaction

Nature and extent of director's interest:

Direct beneficial

 

 

For further information:

Stenprop Limited                                                                                                             44(0)20 3918 6600

Paul Arenson (paul.arenson@stenprop.com)

Julian Carey (julian.carey@stenprop.com)

James Beaumont (james.beaumont@stenprop.com)

 

Numis Securities Limited (Financial Adviser)                                                            44(0)20 7260 1000

Hugh Jonathan

Vicki Paine

 

FTI Consulting (PR Adviser)                                                                                           44(0)20 3727 1000

Dido Laurimore

Richard Sunderland

Richard Gotla

Neel Bose

Stenprop@fticonsulting.com

 

Java Capital Trustees and Sponsors Proprietary Limited                                         27 (0)11 722 3050

(JSE Sponsor)

 

About Stenprop:

Stenprop is a UK REIT listed on the LSE and the JSE. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKKQBNABKDNFK